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Key points 
 We describe a noveldisorder, MORM syndrome, the features of which are 
mild/moderate mental retardation, congenital retinal dystrophy, truncal obesity 
and in males micropenis. 
 We report the locus for this disorder maps to chromosome 9q34.3. 
 The minimal critical region spans 0.5 Mb (~1 cM) between SNPs rs3812547 
and rs2811742 with a maximum multipoint LOD score of 5.64. 
 We believe this to be the first example of the identification of a sub-telomeric 
recessive locus by autozygosity mapping. 
 
 
ABSTRACT 
A consanguineous pedigree is described where fourteen individuals are affected with 
a novel autosomal recessive disorder which causes static moderate mental retardation, 
truncal obesity, a congenital non-progressive retinal dystrophy and micropenis in 
males. We have tentatively named this condition MORM syndrome. It shows 
similarities to Bardet-Biedl syndrome and Cohen syndrome but can be distinguished 
by clinical features; furthermore linkage to the known Bardet-Biedl (BBS1-8) and 
Cohen syndrome loci was excluded. Autozygosity mapping identified a single 
homozygous sub-telomeric region shared by all affecteds on chromosome 9q34.3, 
with a maximum LOD score of 5.64. We believe this to be the first example of the 
identification of a sub-telomeric recessive locus by autozygosity mapping. 
 
 
CLINICAL DETAILS 
Ethical approval for this project was obtained in both the UK and Pakistan. A 
Northern Pakistani pedigree of 9 sib-ships containing 14 affected individuals was 
ascertained. The clinical details were based on the information gathered through 
multiple sources: 1. Interviews with the affected individuals and members of their 
families. 2. Reports from schools, with informed consent from individuals and 
families. 3. Historical information about the development gathered from more than 
one resource, to minimise the chances of recall bias. 4. Intellectual ability assessed by 
MA who is a trained Learning Disability Psychiatrist and has experience of working 
both in the UK and Pakistan, speaks the local language, and has a good knowledge of 
the local cultural norms. 5. Physical development assessed by referring to the norms 
developed for Pakistan and available in the local clinics. 
 
It was difficult to administer any formal IQ test because these individuals had visual 
impairment and also there was a limited choice of tests with normative data for the 
population. The assessment took into consideration the adaptive functioning, the 
impairment caused by visual impairment, and socio-cultural issues. The criteria 
specified in The Diagnostic and Statistical Manual of Mental Disorders (DSM IV)[1] 
was used as a guide for specifying the level of mental retardation. Based on the 
experience of mental retardation as it presents in that population these individuals had 
mild to moderate mental retardation. 
 
The pregnancy and birth of affected individuals was normal, there was no hypotonia 
and polydactyly or other congenital anomalies were not observed. Poor night vision 
was evident within the first year of life. By three years of age reduced visual acuity 
was apparent; however, thereafter no further visual loss occurred. Individuals were 
able to travel around the village using surroundings and familiarity, and were able to 
see large shapes and colour. The occurrence of cataracts in most affected individuals 
in the second or third decade of life lead to a further reduction in visual acuity. 
Examination showed an mildly atrophic retina with thinned blood vessels but without 
increased pigmentation or optic atrophy. All had delayed language acquisition and by 
four years static mild to moderate mental retardation was apparent. Motor milestones 
were normal and hypotonia and spasticity were not observed. By five years minor 
truncal obesity was noticeable in affected children, which became more marked in the 
second decade but neither acanthosis nigricans nor diabetes developed. Males did 
progress through puberty with appropriate growth gain, development of male hair 
pattern and testicular growth, but the penis remained at the prepubescent size. 
Affected males had not been treated with testosterone; therefore it was unclear 
whether there was an end organ resistance to testosterone. Affected individuals 
enjoyed good health and had normal growth parameters; however none were known 
to have born or fathered offspring (Figure 1). Three reputed affected individuals had 
died of natural causes (infection, accident and heart attack) in the preceding decade at 
16y, 25y and 40y respectively. 
 
A simplified family pedigree is shown (Figure 2). The family shows complex 
consanguinity. The inheritance pattern of the disorder is consistent with autosomal 
recessive, with both sexes similarly affected and no parent affected. Cytogenetic 
analysis was normal at 450-850 band quality in two parents and two affected 
individuals. 
 
The kindred live in a valley in the foothills of the Salt Range, in the Punjab of 
Northern Pakistan. Family lore has it that sixteen Arabs settled in the valley 1,000 
years ago, and that since that time descendants have always married within the 
“family”. The village of the descendants has moved twice since its origins to other 
locations within the same valley, most recently to its present location 300 years ago to 
offer greater protection from the marauding of Sikhs in the area at that time. The 
village currently numbers about 5,000 with five different clans. The pedigree with 
affected individuals is a subgroup of one of the clans. The condition is only found in 
this subgroup and all the affected individuals can be traced back to one founding 
couple. There is a strong tradition of inter-marriage in all the clans and their 
subgroups. 
 
 
MOLECULAR GENETICS 
Materials / Methods 
After obtaining informed consent and Ethical Committee permission blood samples 
were collected from 14 affected individuals and 8 of their parents from which DNA 
was extracted using standard methods. To test for linkage to one of the eight BBS or 
Cohen syndrome loci polymorphic microsatellite markers were selected using 
published gene / loci data, the Human Genome Browser and the Genome 
Database.[2][3][4][5][6][7][8][9][10][11] Seven of the affected individuals were 
genotyped with these markers using standard methods: no evidence of linkage was 
found (data not shown). Further examination of the eight BBS loci revealed no 
evidence of triallelic inheritance (data not shown).[12] 
 
A genome wide search for regions of shared homozygosity was performed on the 
family using the Weber Human Screening Set version 8 (Research Genetics), which 
contains 385 autosomal microsatellite repeat markers spaced at approximately 10 cM 
intervals with an average heterozygosity of 0.76. PCR amplification of all markers 
was performed according to the manufacturer’s specifications using a Roboseq 4200 
thermal cycler (MWG Biotech Ltd.). Amplified markers were pooled and 
electrophoresed on an ABI Prism 377 gene sequencer (Applied Biosystems) using 
4.2% polyacrylamide gels at 3000V and 51 C for 2.5 hours. Fragment length analysis 
was conducted using Genescan 3.1.2 and Genotyper 2.5 analysis packages (Applied 
Biosystems). 
 
Fine mapping to reduce the candidate region was conducted by selection of known 
microsatellite repeats from the ABI Linkage Mapping Panel version I (Applied 
Biosystems), the Todd Panel[13] and the Marshfield Linkage Maps. Further 
refinement was achieved by analysing novel microsatellites and single nucleotide 
polymorphisms (SNPs). Novel microsatellites were designed using the Human 
Genome Browser and Primer3 program.[14] Designed microsatellite markers were 
given a designation [human BAC accession number][microsatellite repeat 
unit][number of repeat units in the reference BAC], for example AL449425TA15. 
SNPs were identified using the Human Genome Browser and sequenced using an 
ABI3730xl 96 capillary DNA Analyser (Applied Biosystems) with the ABI BigDye 
Terminator v3.1 (Applied Biosytems), to the manufacturer’s specifications. Sequence 
was analysed using SeqMan II v5.06 software (DNASTAR Inc.) and BLAST 2.[15] 
 
Results 
A region of potential homozygosity was identified in all affected individuals on 
chromosome 9q34.2-34.3 between markers D9S164 and D9S2168. Further refinement 
suggested a common overlap at band q34.3 between markers D9S158 and D9S905 
(Figure 2). Information regarding marker order was derived from analysis of the May 
2004 freeze (HG17 assembly) of the Human Genome Browser. 
 
Multipoint analysis provided further indication of linkage to this region. A fully 
penetrant autosomal recessive mode of inheritance and a disease gene frequency of 
0.0001 were assumed. Due to the complexity of the family structure equal allele 
frequencies were assumed for each marker when calculating LOD scores. Pedigree 
allele inconsistencies were identified using PedCheck.[16] Multipoint analysis was 
performed using the GENEHUNTER v2.1 program[17] for markers in the region, 
with the highest LOD score of 5.64 between markers D9S158 and D9S905 (Figure 3). 
 
Haplotype inspection after analysis of novel microsatellites and SNPs within this 
critical region also confirmed linkage and provided further refinement. The minimum 
critical region as defined by meiotic crossover events is bounded by rs3812547 at 
136.5 Mb and rs2811742 at 137.0 Mb, a genetic distance of approximately 1 cM 
(Table 1). 
Genotype of Affected Individual 
Marker IV:18 V:1 V:2 V:4 V:5 V:6 V:8 V:9 V:10 V:11 VI:1 VI:2 Marker Location (Mb) 
rs12684650 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 136.3 
rs3812547 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 1-2 1-2 2-2 2-2 136.5 
AL592301GCT9 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 1-1 136.6 
rs5901103 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 136.6 
rs2229974 2-2 2-2 2-2 2-2 2-2 2-2 - 2-2 2-2 2-2 2-2 2-2 136.7 
rs11574908 2-2 2-2 2-2 2-2 2-2 2-2 - 2-2 2-2 2-2 2-2 2-2 136.7 
rs10521 2-2 2-2 2-2 2-2 2-2 2-2 - 2-2 2-2 2-2 2-2 2-2 136.7 
rs3125000 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 136.7 
rs3124598 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 136.7 
rs3125004 2-2 2-2 2-2 2-2 2-2 2-2 - - 2-2 2-2 2-2 - 136.7 
rs3124603 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 136.7 
rs3125006 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 136.7 
rs9411208 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 136.7 
rs4489420 2-2 2-2 2-2 2-2 2-2 2-2 - 2-2 2-2 2-2 2-2 2-2 136.7 
rs2811748 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 137.0 
rs2811744 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 137.0 
rs2811742 2-2 2-2 2-2 2-2 2-2 1-2 - 2-2 2-2 2-2 2-2 2-2 137.0 
rs4448378 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 137.1 
AL449425TA15 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-2 2-3 2-3 2-2 2-2 137.1 
 
 DISCUSSION 
We have studied 14 individuals from a single consanguineous pedigree. The number 
and age range of affected individuals within the family allow delineation of the 
clinical features and natural history of a new disorder, which we have termed MORM 
syndrome. The clinical diagnoses of mental retardation were based on assessment of 
adaptive functioning as it was not possible to conduct a formal IQ test. However, the 
assessment was conducted by a clinician experienced in the field of mental retardation 
that had a sound knowledge and understanding of the socio-cultural issues of the local 
population and was fluent in the local language. The name is derived from the 
principle findings; Mental retardation, truncal Obesity, Retinal dystrophy and 
Micropenis. 
 
There are similarities to Cohen syndrome, but the lack of characteristic facies, skin or 
gingival infection, microcephaly and “mottled retina” in the family allow clinical 
differentiation.[18] Bardet-Biedl syndrome is primarily characterised by a rod-cone 
dystrophy with visual problem onset at a mean age of 8.5y (100% over 9y), post axial 
polydactyly (69%), central obesity (72% of post pubertal), mental retardation (62%), 
hypogonadism (97% of males), and renal dysfunction; the figures in brackets being 
from a British clinical survey of cases.[19] Whilst the family would be diagnosable as 
having Bardet-Biedl using Beales’ modified diagnostic criteria (rod-cone dystrophy, 
learning difficulties, obesity and male hypogonadism) age of onset and non-
progressive nature of the visual impairment, and small penis without testicular 
anomalies are atypical.[19] In Bardet-Biedl type BBS5, reported only in 
Newfoundland to date, a small penis is reported with no polydactyly; however, we 
have no evidence of linkage to this or to the other known BBS loci.[20] 
 
We have shown linkage to this condition and a ~1 cM region of 9q34, with a 
maximum LOD score of 5.64. The minimum critical region contains a number of 
potential candidate genes that may cause MORM syndrome, including the cell surface 
neurogenic receptor Notch1 and KIAA0310, which is highly expressed in brain and 
testis. We experienced difficulties in identifying this locus. This was due to both the 
eventual small size of the critical region (which was to be expected given the number 
of affected individuals in the family) and the 9q34 sub-telomeric location (with an 
increased ratio of genetic to physical distance and a paucity of informative 
polymorphic markers). MORM syndrome appears to be phenotypically and 
genetically distinct from the Bardet-Biedl and Cohen syndromes, and is a further 
condition exhibiting obesity / mental retardation with which the clinician has to 
struggle! 
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Online Mendelian Inheritance of Man (OMIM) for clinical and genetic information on 
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Primer3 for design of novel microsatellite repeat markers: 
http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi 
BLAST 2 for SNP sequence analysis: 
http://www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html 
 
 
References 
 
1. American Psychiatric Association. The Diagnostic and Statistical Manual of 
Mental Disorders (DSM IV). Washington DC: American Psychiatric 
Association, 1994. 
2. Mykytyn K, Nishimura DY, Searby CC, et al. Identification of the gene 
(BBS1) most commonly involved in Bardet-Biedl syndrome, a complex 
human obesity syndrome. Nat Genet 2002;31:435-438. 
3. Nishimura DY, Searby CC, Carmi R, et al. Positional cloning of a novel gene 
on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet 
2001;10:865-874. 
4. Young TL, Woods MO, Parfrey PS, et al. Canadian Bardet-Biedl syndrome 
family reduces the critical region of BBS3 (3p) and presents with a variable 
phenotype. Am J Hum Genet 1998;78:461-467. 
5. Mykytyn K, Braun T, Carmi R, et al. Identification of the gene that, when 
mutated, causes the human obesity syndrome BBS4. Nat Genet 2001;28:188-
191. 
6. Young TL, Penney L, Woods MO, et al. A fifth locus for Bardet-Biedl 
syndrome maps to chromosome 2q31. Am J Hum Genet 1999;64:900-904. 
7. Slavotinek AM, Stone EM, Mykytyn K, et al. Mutations in MKKS cause 
Bardet-Biedl syndrome. Nat Genet 2000;26:15-16. 
8. Katsanis N, Beales PL, Woods MO, et al. Mutations in MKKS cause obesity, 
retinal dystrophy and renal malformations associated with Bardet-Biedl 
syndrome. Nat Genet 2000;26:67-70. 
9. Badano JL, Ansley SJ, Leitch CC, et al. Identification of a novel Bardet-Biedl 
syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. 
Am J Hum Genet 2003;72:650-658. 
10. Ansley SJ, Badano JL, Blacque OE, et al. Basal body dysfunction is a likely 
cause of pleiotropic Bardet-Biedl syndrome. Nature 2003;425:628-633. 
11. Kolehmainen J, Norio R, Kivitie-Kallio S, et al. Refined mapping of the 
Cohen syndrome gene by linkage disequilibrium. Eur J Hum Genet 
1997;5:206-213. 
12. Katsanis N. The oligogenic properties of Bardet-Biedl syndrome. Hum Mol 
Genet 2004;13:R65-R71. 
13. Reed PW, Davies JL, Copeman JB, et al. Chromosome-specific microsatellite 
sets for fluorescence-based, semi-automated genome mapping. Nat Genet 
1994;7:390-395. 
14. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for 
biologist programmers. In: Misener S, Krawetz SA, eds. Bioinformatics 
Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana 
Press, 2000;365-386. 
15. Tatusova TA, Madden TL. Blast 2 sequences - a new tool for comparing 
protein and nucleotide sequences. FEMS Microbiol Lett 1999;174:247-250. 
16. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype 
incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-266. 
17. Kruglyak L, Daly MJ, Reeve-Daly MP, et al. Parametric and nonparametric 
linkage analysis: a unified multipoint approach. Am J Hum Genet 
1996;58:1347-1363. 
18. Kivitie-Kallio S, Norio R. Cohen syndrome: essential features, natural history, 
and heterogeneity. Am J Hum Genet 2001;102:125-135. 
19. Beales PL, Elcioglu N, Woolf AS, et al. New criteria for improved diagnosis 
of Bardet-Biedl syndrome: results of a population survey. J Med Genet 
1999;36:437-446. 
20. Woods MO, Young TL, Parfrey PS, et al. Genetic heterogeneity of Bardet-
Biedl syndrome in a distinct Canadian population: evidence for a fifth locus. 
Genomics 1999;55:2-9. 
 
 Figure 1 
The figure shows three of the members of the pedigree affected with MORM 
syndrome, with mental retardation and reduced visual acuity. Dysmorphic features or 
congenital anomalies were not a feature. 
 
 
Figure 2 
Pedigree of the reported family showing closest family links between parents of 
affected individuals. The majority of unaffected individuals have been omitted and 
only the closest consanguineous links between parents are shown. Disease phenotype 
for individuals with MORM syndrome is shown as filled in shapes. Shaded boxes 
denote regions of homozygosity in affected individuals subsequent to fine mapping. 
 
 
Figure 3 
Multipoint analysis of the MORM family across the 9q34.2-34.3 region showing 
LOD score results for markers D9S164, D9S1818, D9S298, D9S312, D9S1826, 
D9S158, D9S905, D9S1838, and D9S2168. 
 
 
Table 1 
The table shows the novel microsatellite markers and SNPs used in the study to 
confirm linkage to chromosome 9q34.3. The markers are listed centromere to qter in 
descending order. The affected individuals are referenced to Figure 2, showing the 
family pedigree (affected individuals IV:3 and V:7 were not typed due to a lack of 
DNA). The genotype is given for each affected person for each marker. The meiotic 
crossovers in each affected are shown in bold / underlined. A dash signifies no result. 
The final column shows the physical location of each marker as derived from the 
Human Genome Browser. 
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Table 
 
Genotype of Affected Subjects 
Microsatellite IV:3 IV:18 V:1 V:2 V:3 V:5 V:6 V:7 V:8 V:9 V:10 V:11 VI:1 VI:2 Lod 
Score 
D9S164 2/2 2/4 - 2/3 2/3 2/3 3/5 3/5 2/3 2/3 - - 1/2 - -10.75 
D9S1818 1/1 1/1 1/1 1/2 1/2 1/1 1/3 1/3 1/1 1/1 - - 1/1 - -0.10 
D9S298 2/2 1/2 2/2 2/2 2/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 - - -0.77 
D9S312 4/4 2/4 4/4 1/4 1/4 2/4 1/4 1/4 2/4 2/4 4/4 - 2/4 - 0.67 
D9S1826 2/2 2/2 2/2 2/2 2/2 2/2 1/2 1/2 2/2 2/2 2/2 2/2 2/2 - 2.84 
D9S158 3/3 3/3 3/3 3/3 3/3 3/3 1/3 1/3 3/3 3/3 3/3 3/3 - 3/3 1.26 
AL592301GCT9 - - - 1/1 - - 1/1 1/1 - - - - 1/1 -  
AL590226AC9 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1  
AL449425TA15 - 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/2 2/3 2/3 2/2 2/2 3.52 
D9S905 2/2 2/2 2/2 2/2 2/2 2/2 - 2/2 2/2 2/2 2/3 2/3 2/2 2/2 0.37 
AL929554GT9 - 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 - - 1/1 -  
AL929554CA9 - 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 - - 1/1 -  
AL929554CCT9 - 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 - - 1/1 -  
AL365502TTA9 - - 1/1 1/1 - - 1/1 1/1 - - - - 1/1 -  
AL365502AAT13 - 1/2 2/2 2/2 2/2 1/2 2/2 2/2 2/2 2/2 - - 2/2 -  
AL590627AC21 - 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 2/3 2/3 2/3 3/3  
D9S1838 - 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 2/3 - 3/3 3/3 1.44 
D9S2168 - 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 1/2 -1.65 
 
 
